Versius Or Laparoscopic Abdominal Hernia REpair (VOLARE)

March 13, 2024 updated by: Joanne Turner

A Single Blinded Randomised Controlled Trial Comparing the Ergonomics of Laparoscopic and Versius Robotic Assisted Abdominal Hernia Surgery

This trial will compare laparoscopic and robotic-assisted abdominal hernia repairs, using the Versius® system. We will initially aim to recruit 60 patients (20 patients in the laparoscopic arm and 40 in the robotic arm) in order to assess the ergonomic impact of each modality on the operating surgeon. This aims to provide in vivo information on whether robotic surgery provides any advantages to the operating surgeon. This trial will also be used to assess the feasibility of recruitment to a future larger study, and any data collected will be used as pilot data.

Study Overview

Status

Not yet recruiting

Detailed Description

This study has been designed to assess the ergonomics of Versius® assisted surgery in comparison with laparoscopic surgery in the management of abdominal hernias. The study will randomise 60 patients who require repair of an abdominal hernia and have been deemed suitable for a minimally invasive approach. Patients will be randomised to receive either laparoscopic or Versius® robotic assisted surgery but will be informed that it will be attempted via a minimally invasive approach that could include either of these two subtypes of minimally invasive surgery.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Pateints diagnosed with an abdominal hernia and are deemed suitable for minimally invasive surgery

Description

Inclusion Criteria:

  • Age ≥18 years
  • Need for abdominal hernia repair surgery

    • Incisional
    • Congenital
  • Deemed suitable for minimally invasive surgery

Exclusion Criteria:

  • Patients who are unable to consent
  • Prisoners
  • Patients in need of emergency surgery
  • Patients with a hernial defect size of over 7cm

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Robotic Arm
This cohort of participants will have their procedure completed by the Versius Surgical Robotic System.
Versius system
Laparoscopic Arm
This cohort of participants will have their procedure completed by a human surgeon.
Surgeon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare the operating surgeon ergonomics (physical strain) of laparoscopic and Versius® robotic assisted surgery
Time Frame: Length of the procedure expected to be between 1-4 hours
body position (physical strain) and cognitive workload (mental strain) assessed using the REBA score
Length of the procedure expected to be between 1-4 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of drop-out (withdrawal) rate of participants
Time Frame: Assessed from Day 1 (Randomisation) to date of withdrawal
Measure the number of participants who withdrawal (drop out) from the trial. The units of measurement will be presented on a scale of numbers of withdrawals versus time.
Assessed from Day 1 (Randomisation) to date of withdrawal
Measurement of the unblinding rate of participants
Time Frame: Through study completion, an average of 1 year.
Measure the number of participants where the treatment is unblinded during the trial. This is measured by the number of participants over the length of time who's treatment is unblinded.
Through study completion, an average of 1 year.
Mental strain of surgeon
Time Frame: 30 minutes maximum completion time per surgeon
To compare the operating surgeon mental strain of each approach using the NASA-Task Load Index score.
30 minutes maximum completion time per surgeon
Health Economics
Time Frame: Procedure and recovery inpatient stay per participant expected to be between 1-3 days.
Explore health economic aspects of each approach via calculation of the entire hospital episode and individual operation (including fixed costs and instrument costs) comparing the cost for cohort using the Versus Surgical Robot versus the human surgeon.
Procedure and recovery inpatient stay per participant expected to be between 1-3 days.
Communication
Time Frame: 1-4 hours expected for the duration of the procedure
To compare differences in in-theatre communication assessed from audiovisual footage, using the Oxford NOTECHS II score.
1-4 hours expected for the duration of the procedure
Measurement of the rate of participant recruitment
Time Frame: Through study completion, an average of 1 year.
Measure the number of participants recruited over the length of time. The units of measurement will be presented on a scale of number of participants over a predetermined length of time.
Through study completion, an average of 1 year.
Satisfaction with life scale
Time Frame: Assessed on Day 14
Quality of life units completion of EQ-5D-5L questionnaire post operatively on day 14. Total scores used not sub scales to be reported.
Assessed on Day 14
Satisfaction with life scale
Time Frame: Assessed on Day 14
Quality of life units completion of MFSI-SF questionnaires post operatively on day 14. Total scores used not sub scales to be reported.
Assessed on Day 14
Length of in-patient stay
Time Frame: Up to 4 weeks
Measure of the time in days of each participant's hospital stay as an in-patient.
Up to 4 weeks
Pain Scores
Time Frame: Days 1, 2, 3, 14 and 28
Using a uni-dimensional pain score measurement examining the change from baseline.
Days 1, 2, 3, 14 and 28

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Barrie Keeler, Consultant Colorectal Surgeon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 31, 2024

Primary Completion (Estimated)

March 31, 2024

Study Completion (Estimated)

March 31, 2024

Study Registration Dates

First Submitted

January 4, 2022

First Submitted That Met QC Criteria

February 21, 2022

First Posted (Actual)

February 24, 2022

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 13, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MKUH-RD-019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Surgery

Clinical Trials on Laparoscopic

3
Subscribe